- Advertise
- Contact Us
- Editorial Info
- Contribute
- Terms and Conditions
- Privacy Policy
- Do not sell my Personal Information
© 2022 MJH Life Sciences™ and Rheumatology Network. All rights reserved.
Psoriatic Arthritis
The Rheumatology Network psoriatic arthritis clinical focus page provides information on the latest psoriatic arthritis news, study and clinical trial findings, and clinical guideline updates. We feature expert interviews with leading physicians and investigators, articles, videos, podcasts, and breaking FDA approvals for psoriatic arthritis drugs.
Psoriatic Arthritis Remission Strongly Associated with Alleviation of Psoriasis Symptoms
August 16, 2022
“Given the complex nature of PsA, patients should also be involved in defining their treatment goals, as every patient may have different perspectives on the target for therapy and the means to achieve it.”
Serum Calprotectin Levels Linked to Subclinical Carotid Atherosclerosis in Patients With Psoriatic Arthritis
August 15, 2022
Serum calprotectin level may be a useful biomarker associated with a high inflammatory burden and the presence of carotid plaque.
Risankizumab Improves Skin, Joint Symptoms in Psoriatic Arthritis
August 10, 2022
Patients with psoriatic arthritis receiving risankizumab reported improved joint and skin symptoms when compared with placebo.
Exercise and Behavioral Approaches Reduce Fatigue in Rheumatic Diseases
August 09, 2022
Exercise and behavioral techniques can be helpful, but they are not often implemented because their effectiveness is unknown and regular face-to-face sessions are undesirable.
Osteoclasts in Patients With PsA, RA Show Functional Differences
August 08, 2022
Results from a small study suggest that psoriatic arthritis and rheumatoid arthritis osteoclasts might retain some of their immune cell functions during differentiation.
Rheumatology Network's Top 5: August 6, 2022
August 06, 2022
Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending August 6, 2022.
FDA Approves Ustekinumab for Pediatric Patients with Psoriatic Arthritis
August 01, 2022
Patients with pediatric psoriatic arthritis will now have access to the first-in-class treatment option, ustekinumab.
Rheumatology Network's Top 5: July 30, 2022
July 30, 2022
Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending July 30, 2022.
Elevated IL-23 Levels Linked to Depression, Anxiety, Disease Activity in PsA
July 27, 2022
“The psychosocial burden of psoriatic arthritis (PsA) has been shown to have a negative effect on the quality of life of the patients. In PsA, psychological disorders can both cause and exacerbate disease development.”
Methotrexate and/or Etanercept Improves Dactylitis, Nail Disease in Early PsA
July 25, 2022
The analysis determined improvement based on a variety of clinical assessments, including the Leeds Enthesitis Index (LEI), Leeds Dactylitis Index (LDI), and modified Nail Psoriasis Severity Index (mNAPSI) scores, at baseline and week 24.